Acción BIOPHARMX CORP
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas BioPharmX Corp OTC Bulletin Board

Acciones

US09072X1019

Precio de cierre OTC Bulletin Board
Otros sitios de cotización
- USD - Gráfico intradía de BioPharmX Corp
04/04 Aprobada la primera petición de ampliación del periodo de exclusividad para Timber Pharmaceuticals, Inc. CI
20/03 Aprobados provisionalmente la segunda declaración de divulgación y el plan revisados de Timber Pharmaceuticals, Inc. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc.
First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc.
LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q).
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc.
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc.
Bidding Procedure Approved for Timber Pharmaceuticals, Inc.
Final DIP Financing Approved for Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals to Be Delisted From NYSE American
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc.
Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción TMBR
  4. Acción
  5. Noticias BioPharmX Corp
  6. Otros idiomas